
    
      The drug being tested in this study is called ramelteon. Ramelteon is being tested to treat
      people who have insomnia with depression. This study will look at sleep activity of
      participants who take ramelteon.

      The study will enroll approximately 30 patients. Participants will be administered:

      â€¢ Ramelteon 8 mg

      Participants will be asked to take 1 tablet orally at bedtime. This multi-center study will
      be conducted in Japan. The overall period to participate in this study is 9 weeks (Run-in
      period for 1 week and treatment period for 8 weeks). Participants will make multiple visits
      to clinic including the final visit 8 weeks after the start of treatment.
    
  